Pura Vida Investments’s BioNTech BNTX Stock Holding History

Pura Vida Investments’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-80,000	Closed	-$11.9M	–	212
2022 Q2	$11.9M	Buy	+80,000	New	+$12.2M	0.69%	41

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Pura Vida Investments's BNTX Position: Q1 2023 in Review

Pura Vida Investments sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 28,195 shares — an estimated $4.24M sold.

Pura Vida Investments first reported a position in BNTX in Q4 2021 and held it in 2 quarters. The position peaked at $4.24M in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

Pura Vida Investments reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 28,195 BioNTech shares in Q1 2023, an estimated $4.24M.
Pura Vida Investments first reported a position in BioNTech in Q4 2021 and held it in 2 quarters.
Pura Vida Investments's BioNTech position peaked at $4.24M in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.